"At Ascension St. John Hospital Academic Hematology Oncology Specialists in Grosse Pointe, Michigan, our doctors and nurses listen to understand your questions and concerns and provide answers to your questions. Then we deliver a care plan with cancer-fighting treatments and support programs. Our medical oncologists and oncology-certified nurses specialize in treating blood cancers such such as leukemia and myeloma with chemotherapy and other novel medications. We’re dedicated to helping you defeat cancer."

During the past decade, Academic Hematology Oncology Specialists conducted 105 clinical trials. In the 10-year time frame, 105 clinical trials started and 23 clinical trials were completed, i.e. on average, 21.9% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 23 clinical trials were completed. i.e. 74.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Academic Hematology Oncology Specialists" #1 sponsor was "National Cancer Institute (NCI)" with 64 trials, followed by "Alliance for Clinical Trials in Oncology" with 22 trials sponsored, "SWOG Cancer Research Network" with 16 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 11 trials sponsored and "NRG Oncology" with 11 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Academic Hematology Oncology Specialists" #1 collaborator was "National Cancer Institute (NCI)" with 58 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Academic Hematology Oncology Specialists" are "Stage IV Lung Cancer AJCC v8" (11 trials), "Stage IVA Lung Cancer AJCC v8" (8 trials), "Stage IVB Lung Cancer AJCC v8" (8 trials), "Recurrent Lung Non-Small Cell Carcinoma" (7 trials) and "Stage IIIB Lung Cancer AJCC v8" (6 trials). Many other conditions were trialed in "Academic Hematology Oncology Specialists" in a lesser frequency.

Most popular intervention types in "Academic Hematology Oncology Specialists" are "Drug" (99 trials), "Other" (70 trials), "Biological" (50 trials), "Procedure" (36 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (36 trials), "Biospecimen Collection" (25 trials), "Computed Tomography" (25 trials), "Questionnaire Administration" (23 trials) and "Laboratory Biomarker Analysis" (22 trials). Other intervention names were less common.

The vast majority of trials in "Academic Hematology Oncology Specialists" are 107 trials for "All" genders, 14 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Academic Hematology Oncology Specialists". undefined are not yet recruiting, 52 are recruiting, 58 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Academic Hematology Oncology Specialists, 4 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Academic Hematology Oncology Specialists, 2 "Phase 1" clinical trials were conducted, 65 "Phase 2" clinical trials and 61 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".